{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:57:46Z","timestamp":1782392266176,"version":"3.54.5"},"reference-count":0,"publisher":"Academy of Family Physicians of Malaysia","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malays Fam Physician"],"published-print":{"date-parts":[[2022,11,30]]},"abstract":"<jats:p>Introduction: Psoriasis affects approximately 2\u20133% of the population worldwide, although the overall prevalence in Asia is &lt;0.5%. Scalp psoriasis is a common initial presentation of psoriasis, which affects almost 80% of patients with psoriasis.\nMethods: This retrospective descriptive study investigated 1,671 patients with psoriasis with scalp involvement registered with the Malaysian Psoriasis Registry (MPR) from January 2007 to December 2018.\nResults: A total of 21,859 patients with psoriasis were registered with the MPR during the study period; among them, scalp involvement was seen in 7.6% (n=1,671). Female sex preponderance (61%) was observed in the majority of Malay patients (58.5%), followed by the Chinese (16.9%), Indian (17.1%) and other ethnic patients (7.5%). A positive family history of psoriasis was identified in 22.7% (n=380). Approximately 34.8% (n=581) and 11% (n=172) of the patients had nail changes and psoriatic arthropathy, respectively. The mainstay treatment modality was topical treatment (93.6%), followed by systemic therapy (10%) and phototherapy (0.5%). The comorbidities found among the patients with scalp psoriasis included hypertension (27.9%), obesity (26%), dyslipidaemia (21%), diabetes mellitus (18.4%), ischaemic heart disease (5.4%) and cerebrovascular disease (1.3%). Approximately 23% reported a Dermatology Life Quality Index (DLQI) of &gt;10, which indicated moderate-to-severe impairment.\nConclusion: The proportion of patients with psoriasis with scalp involvement in our study (7.6%) is much lower than previous reports. Scalp psoriasis markedly negatively impacts the DLQI.<\/jats:p>","DOI":"10.51866\/oa.146","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:31:43Z","timestamp":1670304703000},"page":"84-88","source":"Crossref","is-referenced-by-count":10,"title":["Scalp psoriasis and Dermatology Life Quality Index: A retrospective study based on 12-year data from the Malaysian Psoriasis Registry"],"prefix":"10.51866","volume":"17","author":[{"given":"Wei Cheng","family":"Leong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyh Jong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"28286","published-online":{"date-parts":[[2022,10,20]]},"container-title":["Malaysian Family Physician"],"original-title":[],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:31:44Z","timestamp":1670304704000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-mfp.org\/wp-content\/uploads\/v17n3-OA-Scalp-psoriasis-and-Dermatology.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,11,30]]}},"URL":"https:\/\/doi.org\/10.51866\/oa.146","archive":["CLOCKSS"],"relation":{},"ISSN":["1985-207X","1985-2274"],"issn-type":[{"value":"1985-207X","type":"print"},{"value":"1985-2274","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]}}}